Celecoxib

You have access
Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer
KUNIHIKO KOBAYASHI, KYOICHI KAIRA and HIROSHI KAGAMU

Anticancer Research September 2020, 40 (9) 5309-5311; DOI: https://doi.org/10.21873/anticanres.14537
You have access
Nonsteroidal Anti-inflammatory Drugs Modulate Gene Expression of Inflammatory Mediators in Oral Squamous Cell Carcinoma
DANIELLA MORAES ANTUNES, MARIA FERNANDA SETÚBAL DESTRO RODRIGUES, DOUGLAS MAGNO GUIMARÃES, CARINA MAGALHÃES ESTEVES DUARTE, LUCYENE MIGUITA, LUCIANA CORRÊA, ANA PAULA LIGEIRO DE OLIVEIRA, KRISTIANNE PORTA SANTOS FERNANDES and FABIO DAUMAS NUNES

Anticancer Research May 2019, 39 (5) 2385-2394; DOI: https://doi.org/10.21873/anticanres.13356
You have access
Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell Lines
MICHAEL FRIEDRICH, KATHRIN REICHERT, ALENA WOESTE, STEPHAN POLACK, DOROTHEA FISCHER, FRIEDERIKE HOELLEN, ACHIM RODY, FRANK KÖSTER and MARC THILL

Anticancer Research February 2018, 38 (2) 1201-1207;
You have access
Regulation of miRNA-146a and miRNA-150 Levels by Celecoxib in Premalignant Lesions of K14-HPV16 Mice
RUI M. GIL DA COSTA, RITA ARAÚJO, JOANA M.O. SANTOS, MARA FERNANDES, TIAGO NETO, HUGO SOUSA, JOANA RIBEIRO, MARGARIDA M.S.M. BASTOS, PAULA A. OLIVEIRA, DIOGO CARMO, FÁTIMA CASACA, SANDRA SILVA, CARLOS LOPES and RUI MEDEIROS

Anticancer Research June 2017, 37 (6) 2913-2918;
You have access
Co-treatment with Celecoxib or NS398 Strongly Sensitizes Resistant Cancer Cells to Antimitotic Drugs Independent of P-gp Inhibition
JONG SEUNG LIM, YUJIN PARK, BYUNG MU LEE, HYUNG SIK KIM and SUNGPIL YOON

Anticancer Research October 2016, 36 (10) 5063-5070;
You have access
Celecoxib and LLW-3-6 Reduce Survival of Human Glioma Cells Independently and Synergistically with Sulfasalazine
TOKUNBO YEROKUN and LEYTE L. WINFIELD

Anticancer Research December 2015, 35 (12) 6419-6424;
You have access
Dual Anti-angiogenic Chemotherapy with Temozolomide and Celecoxib in Selected Patients with Malignant Glioma Not Eligible for Standard Treatment
JOHANNES KERSCHBAUMER, FRANZISKA ANNA SCHMIDT, ASTRID ELLEN GRAMS, MARTHA NOWOSIELSKI, DANIEL PINGGERA, KONSTANTIN ROBERT BRAWANSKI, ONDRA PETR, CLAUDIUS THOMÉ, JOCHEN TUETTENBERG, MARCEL SEIZ and CHRISTIAN FRANZ FREYSCHLAG

Anticancer Research September 2015, 35 (9) 4955-4960;
You have access
Effect of Celecoxib on Survival of Mobile Tongue Cancer
DOH YOUNG LEE, JAE HYUN LIM, YOON JOONG KIM, SEONG DONG KIM, SEOK-WOO PARK, SEONG KEUN KWON, J. HUN HAH, TACK-KYUN KWON, KWANG HYUN KIM, YOUNG HO KIM and MYUNG-WHUN SUNG

Anticancer Research July 2015, 35 (7) 4235-4241;
You have access
Combining CAL-101 with Celecoxib Enhances Apoptosis of EBV-transformed B-Cells Through MAPK-induced ER Stress
GA BIN PARK, DAE YOUNG HUR and DAEJIN KIM

Anticancer Research May 2015, 35 (5) 2699-2708;
You have access
Combined Treatment of Breast Cancer Cell Lines with Vitamin D and COX-2 Inhibitors
MARC THILL, KATHRIN REICHERT, ALENA WOESTE, STEPHAN POLACK, DOROTHEA FISCHER, FRIEDERIKE HOELLEN, ACHIM RODY, MICHAEL FRIEDRICH and FRANK KÖSTER

Anticancer Research February 2015, 35 (2) 1189-1195;

Main menu

User menu

Search

Celecoxib

Pages